Cancer (Tumor) Cell Lines
Homo sapiens (Human)
Ovary
Adherent
OVTOKO is a human ovarian clear cell adenocarcinoma cell line established from the metastatic tumor of a 78-year-old female who had received CPA chemotherapy. These cells are negative for hormones estrogen (ER) and progesterone (PR) receptors, and tumor-associated antigens (CA19-9, CA125, and TPA) are not detected in OVTOKO cultures. OVTOKO cells express an evaluated level of epidermal growth factor (EGF). When transplanted into mice, OVTOKO cells are capable of forming tumors subcutaneously and in the abdominal cavity, and intraperitoneal injection results in peritoneal spread and distant metastasis. OVTOKO cell line provides a significant experimental cell models to investigate the tumorigenesis and malignant progression of human ovarian clear cell adenocarcinoma.
MIR31 Knockout IPEC-J2 Cell Line
Cat. No. ARG43980
LIMCH1 Knockout SK-HEP-1 Polyclonal Cells
Cat. No. ARG16248
KNOP1 Knockout 786-O Polyclonal Cells
Cat. No. ARG25439
ACAP2 Knockout huh-7 Polyclonal Cells
Cat. No. ARG27771
LAMP1 Knockout CaSki Polyclonal Cells
Cat. No. ARG9766
CETN2 Knockout Raji Polyclonal Cells
Cat. No. ARG1345
Complete description is available upon request.